Skip to main content

Table 1 Patient characteristics by treatment type

From: Comparison of baseline quality of life measures between renal cell carcinoma patients undergoing partial versus radical nephrectomy

Variable 1

NSS (N = 71)

RN (N = 73)

p-value

Age at diagnosis (years)

  

0.283

  < 65

36 (51%)

34 (47%)

 

  ≥ 65

35 (49%)

39 (53%)

 

Male

45 (63%)

51 (70%)

0.482

Race - white

65 (92%)

64 (88%)

0.592

Marital Status

  

1.002

  Married

55 (77%)

57 (78%)

 

  Widowed, Divorced, Single

16 (23%)

16 (22%)

 

Education

  

0.112

  HS Graduate/GED

8 (11%)

15 (21%)

 

  1-3 Vocational/Some College

30 (42%)

20 (27%)

 

  College Graduate/Graduate School

29 (41%)

29 (40%)

 

  Other/Unknown

4 (6%)

9 (12%)

 

BMI

  

0.0723

  < 30

35 (49%)

43 (59%)

 

  ≥ 30

36 (51%)

30 (41%)

 

ECOG Performance Status

n = 69

n = 72

0.762

  0 – Fully active

64 (93%)

65 (90%)

 

  1, 2 – Some restriction

5 (7%)

7 (10%)

 

Karnofsky Performance Status

n = 62

n = 64

0.623

  100

55 (89%)

55 (86%)

 

  70 - 90

7 (11%)

9 (14%)

 

Histologic Subtype

  

0.852

  Clear cell

46 (65%)

49 (67%)

 

  Papillary/Chromophobe/RCC

16 (23%)

17 (23%)

 

  Oncocytoma/Angiomyolipoma/Other benign

9 (13%)

7 (10%)

 

Nuclear grade

n = 62

n = 66

0.0013

  1-2

51 (82%)

40 (61%)

 

  3-4

11 (18%)

26 (39%)

 

Charlson score

  

0.183

  0

37 (52%)

35 (48%)

 

  1-2

28 (39%)

21 (29%)

 

  3-4

6 (8%)

11 (15%)

 

  ≥ 5

0 (0%)

6 (8%)

 

Tumor Stage

n = 62

n = 65

<0.0012

  pT1a/pT1b

59 (95%)

39 (60%)

 

  pT2

1 (2%)

10 (15%)

 

  pT3a/pT3b

2 (3%)

16 (25%)

 
  1. 1The sample median (minimum, 25th percentile, 75th percentile, maximum) is given for numerical variables, n (%) for categorical variables.
  2. 2P-values result from Fisher’s exact test.
  3. 3P-values result from Wilcoxon rank sum test (although data is presented categorically).